Syncom Formulations (India) Limited (BOM:524470)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Pharmaceuticals Drugs & Formulations	5.16B	4.70B	2.62B	2.10B	2.20B
Trading of Commodities	11.00M	82.58M	107.13M	255.24M	94.23M
Renting of Property	36.77M	39.15M	40.19M	33.53M	26.86M
Total	5.21B	4.82B	2.77B	2.39B	2.32B

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Export	3.80B	1.77B	1.44B	1.55B
India	751.11M	782.94M	788.12M	627.88M
Unallocated	72.68M	34.57M	17.68M	18.39M
Total	4.63B	2.58B	2.25B	2.20B

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 17, 2026

Data Sources Report a data error